Thermo Fisher Stock Surges as Medical Device Maker’s Results Top Estimates

Key Takeaways

Shares of Thermo Fisher Scientific (

TMO

) rose Thursday after the medical device maker’s fourth-quarter results topped analysts’ estimates.

Thermo Fisher reported revenue of $11.4 billion, up about 5% year-over-year and better than the $11.28 billion Visible Alpha consensus. Profit narrowly beat estimates at $1.83 billion, or $4.78 per share, up from $4.20 a year ago. Adjusted
earnings per share (EPS)
of $6.10 also topped expectations.

Sales increased across all four of the company’s divisions, with revenue at its largest segment, Laboratory Products and Biopharma Services, rising 4%. Last quarter, shares fell as sales
were flat or declined
in two segments.

Thermo Fisher shares were up 6.6% intraday after entering Thursday roughly flat over the prior 12 months.

Read the original article on
Investopedia